The Medicare GLP-1 Bridge now continues through the end of 2027

How to read this guide

This is general educational information, not a plan quote, coverage determination, medical recommendation, or promise of eligibility or savings. Facts were checked against the official sources listed below and are current as of August 14, 2026.

An older couple reviewing their household priorities together at a kitchen table — People before policiesA coverage review should begin with the life you already have—not a predetermined plan or product.Illustrative editorial scene featuring fictional people—not a client testimonial.

What CMS changed for 2027

CMS extended the short-term Medicare GLP-1 Bridge through December 31, 2027 after the planned BALANCE Model did not launch in 2027. The Bridge began July 1, 2026 and provides certain eligible Part D beneficiaries access to certain GLP-1 drugs outside the normal Part D payment flow.

This is a temporary demonstration, not a permanent addition to every Medicare drug plan. Eligibility and access must be determined through the official Medicare process.

How the $50 copay works

CMS states that an eligible beneficiary has a $50 copay for an eligible GLP-1 drug furnished through the Bridge. Because the demonstration operates outside Part D’s coverage and payment flow, the Part D deductible does not apply to that Bridge drug.

CMS also states that the $50 copay does not count toward Part D true out-of-pocket costs and that the Part D low-income subsidy does not apply to Bridge drugs. Those details matter when planning total prescription spending for the year.

$50 copay for an eligible beneficiary receiving an eligible Bridge drug.
The Part D deductible does not apply to the Bridge drug.
The $50 does not count toward Part D true out-of-pocket spending.
The Part D low-income subsidy does not reduce the Bridge copay.

An older man and his adult daughter reviewing a medication routine together — A practical momentMedication conversations should stay grounded in official eligibility information and the individual’s current coverage.Illustrative editorial scene featuring fictional people—not a client testimonial or representation of coverage or results.

Eligibility is not automatic

Having Medicare Part D, using a GLP-1 medication, or having a particular diagnosis does not by itself prove eligibility. CMS directs people with Medicare to its official GLP-1 Bridge page to check whether they might qualify.

Boyd Financial Group does not make medical-necessity, prior-authorization, or program-eligibility decisions. Those decisions belong to CMS and the program’s official process, with treatment decisions made between the patient and clinician.

Use Medicare.gov or call 1-800-MEDICARE for the current eligibility rules. Do not email a Medicare number or detailed health information to request a preliminary determination.

Questions worth asking

If you think the Bridge may apply, gather the exact prescription information and contact Medicare. Ask how eligibility is determined, how prior authorization works, which drugs qualify, where an eligible prescription can be filled, and what happens when the demonstration ends.

Primary sources

Official references

Medicare GLP-1 BridgeCMSCMS page last modified July 13, 2026 when reviewed.
Medicare GLP-1 Bridge eligibility informationMedicare.gov

CMS and Medicare guidance can change. Verify the current official document before relying on a date, amount, eligibility rule, or process.

Keep the conversation focused

Have a Medicare question for Lee?

Call Lee directly or request general Medicare information by email. Calling or emailing does not obligate you to enroll and does not affect your current coverage.

Schedule your review today Get Medicare information now